| Name | Progesterone |
| Description | Progesterone is a steroid hormone that regulates the menstrual cycle and is essential for pregnancy. It is also commonly used to induce melasma models. |
| In vitro | Progesterone drives a series of events in which luminal cells may furnish basal cells with Wnt4 and RANKL signals, which in turn respond by upregulating homologous receptors, transcriptional targets, and markers of the cell cycle. Progesterone exhibits a biphasic effect on the proliferation of breast cancer cells; it stimulates growth during the initial cell cycle and subsequently impedes cell progression at the G1/S phase. |
| In vivo | Twenty-one days after dorsal medial thalamic nuclei damage, rats treated with progesterone exhibited reduced neuronal degeneration. In female 3xTg-AD mice, progesterone negated the advantageous effects against Abeta accumulation, yet it did not affect behavioral performance. During the Morris water maze spatial navigation task, progesterone-treated rats demonstrated less impairment compared to control rats. |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (6.36 mM), Sonication is recommended.
Ethanol : 31.5 mg/mL (100.17 mM), Sonication is recommended.
Methanol : < 1 mg/mL (insoluble)
DMSO : 47.48 mg/mL (150.99 mM), Sonication and heating are recommended.
|
| Keywords | κ-opioid receptor | progestogenReceptor | progestogen Receptor | ProgesteroneReceptor | Progesterone Receptor | Progesterone | OpioidReceptor | Opioid Receptor | NR3C3 | Inhibitor | inhibit | EstrogenReceptor | Estrogen Receptor | ER | EndogenousMetabolite | Endogenous Metabolite |
| Inhibitors Related | Sucrose | Aceglutamide | L-Pyroglutamic acid | Emtricitabine | Levulinic acid | D(+)-Raffinose pentahydrate | D-(+)-Trehalose dihydrate | Glycerol | Thymidine | Gluconate Calcium | Chitosan oligosaccharide | 3-Indoleacetic acid |
| Related Compound Libraries | Anti-Tumor Natural Product Library | Failed Clinical Trials Compound Library | Pain-Related Compound Library | Anti-Neurodegenerative Disease Compound Library | Membrane Protein-targeted Compound Library | Natural Product Library for HTS | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Bitter Compound library | Bioactive Compounds Library Max | GPCR Compound Library | Ancient Chinese Classical Formulas Compound Library |
United States
